LABD:ARCA-Direxion Daily S&P Biotech Bear 3X Shares (USD)

ETF | Trading--Inverse Equity | NYSE Arca

Last Closing

USD 8.53

Change

+0.37 (+4.53)%

Market Cap

USD 0.10B

Volume

0.01B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index. The index includes domestic companies from the biotechnology industry. The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.55%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-08 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.89 %

N/A

USD 0.98B
SOXS Direxion Daily Semiconductor B.. 0.97 %

N/A

USD 0.70B
SPXU ProShares UltraPro Short S&P50.. 0.91 %

N/A

USD 0.60B
PSQ ProShares Short QQQ 0.95 %

N/A

USD 0.55B
SDS ProShares UltraShort S&P500 0.89 %

N/A

USD 0.55B
SPXS Direxion Daily S&P 500® Bear .. 0.95 %

N/A

USD 0.52B
TZA Direxion Daily Small Cap Bear .. 0.95 %

N/A

USD 0.39B
SDOW ProShares UltraPro Short Dow30 0.95 %

N/A

USD 0.30B
QID ProShares UltraShort QQQ 0.95 %

N/A

USD 0.26B
SPDN Direxion Daily S&P 500® Bear .. 0.45 %

N/A

USD 0.19B

ETFs Containing LABD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.97% 45% F 12% F
Dividend Return 0.69% 21% F 35% F
Total Return -11.29% 43% F 12% F
Trailing 12 Months  
Capital Gain -33.10% 38% F 7% C-
Dividend Return 3.47% 45% F 51% F
Total Return -29.63% 39% F 7% C-
Trailing 5 Years  
Capital Gain -98.07% 11% F 1% F
Dividend Return 0.87% 9% A- 3% F
Total Return -97.20% 11% F 1% F
Average Annual (5 Year Horizon)  
Capital Gain 30.07% 73% C 90% A-
Dividend Return 30.68% 73% C 89% A-
Total Return 0.61% 23% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 974.48% 27% F 1% F
Risk Adjusted Return 3.15% 64% D 29% F
Market Capitalization 0.10B 68% D+ 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.